Dysferlin overexpression in skeletal muscle produces a progressive myopathy.
Dysferlin overexpression in skeletal muscle produces a progressive myopathy.
复制标题
DOI:
10.1002/ana.21926
复制
发表时间:
2010-03
影响因子:
11.2
通讯作者:
Brown, Robert H., Jr.
中科院分区:
文献类型:
--
作者:
Glover, Louise E.;Newton, Kimberly;Krishnan, Gomathi;Bronson, Roderick;Boyle, Alexandra;Krivickas, Lisa S.;Brown, Robert H., Jr.
The dose-response effects of dysferlin transgenesis were analyzed to determine if the dysferlin-deficient myopathies are good candidates for gene replacement therapy. We have generated three lines of transgenic mice, expressing low, mid and high levels of full-length human dysferlin from a muscle-specific promoter. Transgenic skeletal muscle was analyzed and scored for morphological and functional deficits. Overexpression of dysferlin in mice resulted in a striking phenotype of kyphosis, irregular gait and reduced muscle mass and strength. Moreover, protein dosage correlated with phenotype severity. In contrast to dysferlin-null skeletal muscle, no evidence of sarcolemmal impairment was revealed. Rather, increased levels of Ca2+-regulated, dysferlin-binding proteins and ER stress chaperone proteins were observed in muscle lysates from transgenic mice as compared to controls. Expression levels of dysferlin are important for appropriate function without deleterious or cytotoxic effects. As a corollary, we propose that future endeavors in gene replacement for correction of dysferlinopathy should be tailored to take account of this.
登录
查看更多内容
影响因子:
3.5
作者:
Fujita, Eriko;Kouroku, Yoriko;Momoi, Takashi
通讯作者:
Momoi, Takashi
影响因子:
3.5
作者:
Anderson, LVB;Davison, K;Bushby, KMD
通讯作者:
Bushby, KMD
影响因子:
82.9
作者:
Gregorevic, Paul;Allen, James M.;Chamberlain, Jeffrey S.
通讯作者:
Chamberlain, Jeffrey S.
影响因子:
11.2
作者:
Ho, MF;Gallardo, E;Brown, RH
通讯作者:
Brown, RH
影响因子:
2.5
作者:
BISCHOFF, R;HEINTZ, C
通讯作者:
HEINTZ, C